This federal contract award, valued at $13,935.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a delivery order for the provision of CIBINQO 100 MG TABLET pharmaceutical products. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,511.02 firm fixed-price delivery order contract covers the supply of CIBINQO 100 MG TABLET UU 30S, a medical product, with a performance period extending through March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $3,400.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides for the delivery of CIBINQO 100 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $7,246.38 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIBINQO 100 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through June 26, 2025. The contract is not set aside and was awarded under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,470.94 firm fixed price contract is for the delivery of CIBINQO 50 MG TABLET UU 30S, a specialty pharmaceutical product. It has an ultimate completion date of April 17, 2023. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $10,238.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, and has a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. In addition to this specific contract,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $5,119.36 firm fixed-price delivery order contract is for the supply of INQOVI 35 MG-100 MG tablets. The contract has an ultimate completion date of April 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order from the Defense Logistics Agency (DLA) valued at $5,119.36. The contract is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through March 13, 2025 and is a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award, valued at $9,660.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of INQOVI 35 MG-100 MG tablets, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of November 5, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific...